Acral Pigmentation in Peutz-Jeghers Syndrome : Dermoscopic Findings and Treatment with the Q-Switched Nd:YAG Laser
Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatology..
Peutz-Jeghers syndrome (PJS; MIM 175200) is an autosomal dominant multiple-organ cancer syndrome. It is characterized by brown macules distributed in the perioral skin, oral mucosa, hands and feet, and hamartomatous gastrointestinal polyps that can eventually lead to intestinal obstruction, abdominal pain, bleeding, and anemia. Patients with PJS are at a higher risk of ovarian, testicular, breast, lung, and pancreatic cancers. This predisposition is due to the pathogenic variant in serine/threonine kinase 11 (STK11) gene located on chromosome 19p13.3. Here, we present the dermoscopic findings, histopathologic features of acral pigmentation, and DNA sequencing results of the patient with PJS. We also report a successful removal of acral pigmentation using the Q-switched Nd:YAG laser (QSNYL) treatment. Our results suggest that QSNYL therapy could be a treatment option for acral pigmentation in patients with PJS.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
Annals of dermatology - 35(2023), Suppl 2 vom: 05. Nov., Seite S201-S204 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shin, Hyeonwoo [VerfasserIn] |
---|
Links: |
---|
Themen: |
Case Reports |
---|
Anmerkungen: |
Date Revised 20.12.2023 published: Print Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.5021/ad.21.215 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365525936 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365525936 | ||
003 | DE-627 | ||
005 | 20231227134906.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.5021/ad.21.215 |2 doi | |
028 | 5 | 2 | |a pubmed24n1233.xml |
035 | |a (DE-627)NLM365525936 | ||
035 | |a (NLM)38061703 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Shin, Hyeonwoo |e verfasserin |4 aut | |
245 | 1 | 0 | |a Acral Pigmentation in Peutz-Jeghers Syndrome |b Dermoscopic Findings and Treatment with the Q-Switched Nd:YAG Laser |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.12.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatology. | ||
520 | |a Peutz-Jeghers syndrome (PJS; MIM 175200) is an autosomal dominant multiple-organ cancer syndrome. It is characterized by brown macules distributed in the perioral skin, oral mucosa, hands and feet, and hamartomatous gastrointestinal polyps that can eventually lead to intestinal obstruction, abdominal pain, bleeding, and anemia. Patients with PJS are at a higher risk of ovarian, testicular, breast, lung, and pancreatic cancers. This predisposition is due to the pathogenic variant in serine/threonine kinase 11 (STK11) gene located on chromosome 19p13.3. Here, we present the dermoscopic findings, histopathologic features of acral pigmentation, and DNA sequencing results of the patient with PJS. We also report a successful removal of acral pigmentation using the Q-switched Nd:YAG laser (QSNYL) treatment. Our results suggest that QSNYL therapy could be a treatment option for acral pigmentation in patients with PJS | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Dermoscopy | |
650 | 4 | |a Genetics | |
650 | 4 | |a Hand | |
650 | 4 | |a Lasers | |
650 | 4 | |a Peutz-Jeghers syndrome | |
650 | 4 | |a Pigmentation | |
700 | 1 | |a Hur, Keunyoung |e verfasserin |4 aut | |
700 | 1 | |a Lee, Jee-Soo |e verfasserin |4 aut | |
700 | 1 | |a Seong, Moon-Woo |e verfasserin |4 aut | |
700 | 1 | |a Mun, Je-Ho |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annals of dermatology |d 1996 |g 35(2023), Suppl 2 vom: 05. Nov., Seite S201-S204 |w (DE-627)NLM088836355 |x 2005-3894 |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2023 |g number:Suppl 2 |g day:05 |g month:11 |g pages:S201-S204 |
856 | 4 | 0 | |u http://dx.doi.org/10.5021/ad.21.215 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2023 |e Suppl 2 |b 05 |c 11 |h S201-S204 |